Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06771492

Efficacy of Antibiotic Treatment for Patients With Chronic Low Back Pain and Modic Type I Changes - Randomized Placebo-controlled Trial

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
204 (estimated)
Sponsor
Bart Koes · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if antibiotics (amoxicillin) work to treat chronic low back pain in adults. In some patients, this type of back pain may be caused by bacteria in the vertebrae, resulting in a condition known as "Modic type I change." The main questions the trial aims to answer are: * What is the efficacy (primary objective) of antibiotic treatment for patients with chronic low back pain and Modic type I changes? * What is the cost-effectiveness (secondary objective) of antibiotic treatment for patients with chronic low back pain and Modic type I changes? Researchers will compare amoxicillin to a placebo (a look-alike substance that contains no active drug) to see if amoxicillin works to treat chronic low back pain. Participants in the trial will: * Be invited for an MRI scan to determine if they have a Modic type I change; those who do will be included in the study. * Take either amoxicillin or a placebo daily for 100 days. * Take probiotics daily for 100 days to reduce the occurrence and impact of any side effects from the antibiotics. * Attend clinic visits at baseline (the start), 4 weeks, 3 months, and 12 months for checkups and tests. * Complete questionnaires at baseline, 3 months, 6 months, and 12 months.

Conditions

Interventions

TypeNameDescription
DRUGAmoxicillinAntibiotic treatment (amoxicillin) with a dosage of 1000 mg (3 times a day) for a period of 100 days
OTHERPlaceboPlacebo with a dose of 1000 mg (3 times a day) for a period of 100 days

Timeline

Start date
2025-04-02
Primary completion
2027-08-01
Completion
2027-08-01
First posted
2025-01-13
Last updated
2025-08-06

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06771492. Inclusion in this directory is not an endorsement.